NDC 74527-022

MARGENZA

Margetuximab-cmkb

MARGENZA is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Macrogenics, Inc. The primary component is Margetuximab.

• Product ID: 74527-022_30b9c9b4-90e1-4478-aad7-f8cae4dbf1dc
• NDC: 74527-022
• Product Type: Human Prescription Drug
• Proprietary Name: MARGENZA
• Generic Name: Margetuximab-cmkb
• Dosage Form: Injection, Solution, Concentrate
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-01-15
• Marketing Category: BLA / BLA
• Application Number: BLA761150
• Labeler Name: MacroGenics, Inc
• Substance Name: MARGETUXIMAB
• Active Ingredient Strength: 25 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 74527-022-02

1 VIAL, SINGLE-DOSE in 1 CARTON (74527-022-02) > 10 mL in 1 VIAL, SINGLE-DOSE (74527-022-01)

• Marketing Start Date: 2021-01-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details